Key Insights

Highlights

Treatment Research

1 treatments under study, led by Pace Program

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Pace Program1

Active Sponsors

  • National Institute on Aging (NIA)1
  • University of North Carolina, Chapel Hill1

Top Investigators

Related Conditions

  • Rubinsteintaybi Syndrome1
  • Intellectual Disability1
  • Praderwilli Syndrome1
  • Trisomy 13 Syndrome1
  • Wagr Syndrome1

Activity Timeline